| |
Dear Shareholders,
I am providing this
update regarding the CardioComm Solutions'
Private Placement Opportunity. Specifically,
interested investors should be aware that the
private placement opportunity may have to be
re-priced based on market value of our shares,
especially a market shares value change occurs
following a press releases we make.
Share prices under our open $1M private
placement have been based on a discount to the
market. We initially priced shares at $0.12 and
then re-priced at $0.0675 based on a change
(lowering) of the market share price for our
stock.
(see
http://www.cardiocommsolutions.com/news/2014/CCSnews_010914.html)
We are now at the end of the second week
following announcing a 6.75 cent per share
investment opportunity and we have close a first
tranche of that investment opportunity in the
$100,000 range.
Our stock now has a market price of 10.50 cents
per share. If we were to close a tranche of
equity financing now, the best discount at 25%
would be an $0.08 per share offer. The original
option of $0.0675 was based on a market share
price of $0.09 per share.
We are taking this opportunity to provide
advanced notice to anyone who was interested in
the 6.75 cent per share offering, that we may
need to re-price the offer at $0.08 based on a
closing market price for our $0.105 per share
(today's market price).
As we cannot determine what the market may do
with respect to stock price, we wish to advise
our shareholders that any discounted share price
offer may not be possible to maintain for an
extended period of time especially following any
press release that CardioComm Solutions may
make.
Should you have an interest to be involved or
would like more information, please contact me
by email at egrima@cardiocommsolutions.com or
directly at 416-977-9425 ext. 227 to discuss in
further detail.
Kind regards,
Etienne Grima CEO of CardioComm Solutions, Inc.
The
Medical Post Article
Forward-looking
statements
This release may contain certain forward-looking
statements with respect to the financial
condition, results of operations and business of
CardioComm Solutions and certain of the plans
and objectives of CardioComm Solutions with
respect to these items. By their nature,
forward-looking statements involve risk and
uncertainty because they relate to events and
depend on circumstances that will occur in the
future and there are many factors that could
cause actual results and developments to differ
materially from those expressed or implied by
these forward-looking statements.
|
